A pharmacogenetic analysis of peripheral sensory neuropathy related to administration of taxanes in breast cancer patients.

被引：4
|
作者：
Leonard, Alyson
Gudena, Vinay K.
机构：
[1] Cone Hlth Canc Ctr, Burlington, NC USA
[2] Cone Hlth Canc Ctr, Greensboro, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e13133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13133
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes
    Angelini, Silvia
    Botticelli, Andrea
    Onesti, Concetta Elisa
    Giusti, Raffaele
    Sini, Valentina
    Durante, Valeria
    Strigari, Lidia
    Gentile, Giovanna
    Cerbelli, Bruna
    Pellegrini, Patrizia
    Sgroi, Valentina
    Occhipinti, Mario
    Di Pietro, Francesca Romana
    Rossi, Alessandro
    Simmaco, Maurizio
    Mazzuca, Federica
    Marchetti, Paolo
    ANTICANCER RESEARCH, 2017, 37 (05) : 2633 - 2639
  • [2] Neuromuscular ultrasound for the non-invasive assessment of breast cancer patients with peripheral neuropathy from taxanes
    Strowd, Roy
    Lycan, Thomas
    Thomas, Alexandra
    Hsu, Fang-Chi
    Ahn, Christine
    Sangueza, Omar
    Shiozawa, Yusuke
    Park, Sun Hee
    Peters, Chris
    Romero-Sandoval, Edgar Alfonso
    Melin, Susan
    Sorscher, Steven
    Lesser, Glenn
    Walker, Francis
    Cartwright, Michael
    NEUROLOGY, 2019, 92 (15)
  • [3] Predictors of chemotherapy-induced peripheral neuropathy among breast cancer patients treated with taxanes.
    Candelario, Nellowe
    Wongrakpanich, Supakanya
    Morginstin, Mark S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [4] Peripheral nerve damage associated with administration of taxanes in patients with cancer
    Argyriou, Andreas A.
    Koltzenburg, Martin
    Polychronopoulos, Panagiotis
    Papapetropoulos, Spiridon
    Kalofonos, Haralabos P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (03) : 218 - 228
  • [5] Paclitaxel-induced peripheral neuropathy in early-stage breast cancer patients.
    Liu, Jacqueline
    Sorooshian, Hormozan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
    van Haren, Frank
    van den Heuvel, Sandra
    Ligtenberg, Mandy
    Vissers, Kris
    Steegers, Monique
    CANCER REPORTS, 2022, 5 (10)
  • [7] Prospective observational study of breast cancer patients during the cycle of chemotherapy with taxanes: evaluation of the incidence and prevalence of peripheral neuropathy
    Luz, Roberta P. Costa
    Alliz, Carmen S.
    Rizzi, Samantha K. Lopes de Almeida
    Haddad, Cinira
    Machado, Christiano Bittencourt
    Nazario, Afonso
    Facina, Gil
    CANCER RESEARCH, 2023, 83 (05)
  • [8] Feasibility of quantitative sensory testing (QST) in clinical routine as a tool to evaluate chemotherapy-induced peripheral neuropathy (CIPN) amongst breast cancer patients treated with taxanes
    Ioannou, I.
    Utpadel-Fischler, D.
    Toelle, T.
    Kiechle, M.
    Ettl, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] Investigating the effect of zinc on the prevention of acute peripheral neuropathy in cancer patients treated with taxanes
    Haji Gholami, Ali
    Ansari, Hourieh
    Fardani, Farshad
    ADVANCED BIOMEDICAL RESEARCH, 2022, 11 (01): : 61
  • [10] Association of Met-BDNF allele with pre-existing peripheral neuropathy in breast cancer patients.
    Azoulay, David
    Leibovici, Anca
    Sharoni, Rivka
    Goldberg, Hadassah
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345